Covered recipient · General Payments record
RACHEL SENNETT
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2020–2023
$506.25
- Reported across 19 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $189.09 | 9 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $49.84 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $32.37 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $24.50 | 1 |
| ABBVIE INC. | $21.52 | 1 |
| LEO Pharma Inc. | $16.99 | 1 |
| E.R. Squibb & Sons, L.L.C. | $15.24 | 1 |
| Lilly USA, LLC | $14.48 | 1 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $14.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $21.52 | 01/25/2023 | Food and Beverage | Undisputed | 06/30/2026 | 998907185 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $32.37 | 01/03/2023 | Food and Beverage | Undisputed | 06/30/2026 | 996771081 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.24 | 03/29/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1015532611 | CMS |
| GENZYME CORPORATION | $32.25 | 02/28/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1049933631 | CMS |
| GENZYME CORPORATION | $17.59 | 05/23/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1049933687 | CMS |
| LEO Pharma Inc. | $16.99 | 03/28/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1053526527 | CMS |
| Lilly USA, LLC | $14.48 | 04/25/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1032019869 | CMS |
| Novartis Pharmaceuticals Corporation | $24.50 | 03/07/2023 | Food and Beverage | Undisputed | 06/30/2026 | 993303333 | CMS |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $14.15 | 08/23/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1051621487 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2020, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2020 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.